-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Upgrades AVITA Medical to Buy, Raises Price Target to $6

Benzinga·05/15/2026 17:44:28
Listen to the news
Lake Street analyst Frank Takkinen upgrades AVITA Medical (NASDAQ:RCEL) from Hold to Buy and raises the price target from $3.5 to $6.